Correlation Between Pfizer and Amg Chicago
Can any of the company-specific risk be diversified away by investing in both Pfizer and Amg Chicago at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Amg Chicago into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Amg Chicago Equity, you can compare the effects of market volatilities on Pfizer and Amg Chicago and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Amg Chicago. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Amg Chicago.
Diversification Opportunities for Pfizer and Amg Chicago
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Amg is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Amg Chicago Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amg Chicago Equity and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Amg Chicago. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amg Chicago Equity has no effect on the direction of Pfizer i.e., Pfizer and Amg Chicago go up and down completely randomly.
Pair Corralation between Pfizer and Amg Chicago
If you would invest 1,532 in Amg Chicago Equity on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Amg Chicago Equity or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Pfizer Inc vs. Amg Chicago Equity
Performance |
| Timeline |
| Pfizer Inc |
| Amg Chicago Equity |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Amg Chicago Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Amg Chicago
The main advantage of trading using opposite Pfizer and Amg Chicago positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Amg Chicago can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amg Chicago will offset losses from the drop in Amg Chicago's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |